Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go
- PMID: 26828520
- PMCID: PMC4773742
- DOI: 10.3390/cancers8020019
Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go
Abstract
Cancers are heterogeneous tissues comprised of multiple components, including tumor cells and microenvironment cells. The tumor microenvironment has a critical role in tumor progression. The tumor microenvironment is comprised of various cell types, including fibroblasts, macrophages and immune cells, as well as extracellular matrix and various cytokines and growth factors. Fibroblasts are the predominant cell type in the tumor microenvironment. However, neither the derivation of tissue-specific cancer-associated fibroblasts nor markers of tissue-specific cancer-associated fibroblasts are well defined. Despite these uncertainties it is increasingly apparent that cancer-associated fibroblasts have a crucial role in tumor progression. In breast cancer, there is evolving evidence showing that breast cancer-associated fibroblasts are actively involved in breast cancer initiation, proliferation, invasion and metastasis. Breast cancer-associated fibroblasts also play a critical role in metabolic reprogramming of the tumor microenvironment and therapy resistance. This review summarizes the current understanding of breast cancer-associated fibroblasts.
Keywords: breast cancer; cancer-associated fibroblasts; tumor microenvironment.
Similar articles
-
Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression.Cancer Lett. 2015 Jun 1;361(2):155-63. doi: 10.1016/j.canlet.2015.02.018. Epub 2015 Feb 17. Cancer Lett. 2015. PMID: 25700776 Review.
-
The role of cancer-associated fibroblasts in breast cancer pathobiology.Histol Histopathol. 2016 Apr;31(4):371-8. doi: 10.14670/HH-11-700. Epub 2015 Dec 2. Histol Histopathol. 2016. PMID: 26627101 Review.
-
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review.
-
Involvement of Breast Cancer-Associated Fibroblasts in Tumor Development, Therapy Resistance and Evaluation of Potential Therapeutic Strategies.Curr Med Chem. 2018;25(29):3414-3434. doi: 10.2174/0929867325666180309120746. Curr Med Chem. 2018. PMID: 29521203 Review.
-
[Breast cancer invasion: the key role of normal cells of host tissues].Bull Acad Natl Med. 1994 Mar;178(3):533-42; discussion 542-4. Bull Acad Natl Med. 1994. PMID: 8076190 Review. French.
Cited by
-
Response prediction to oxaliplatin plus 5-fluorouracil chemotherapy in patients with colorectal cancer using a four-protein immunohistochemical model.Oncol Lett. 2019 Aug;18(2):2091-2101. doi: 10.3892/ol.2019.10474. Epub 2019 Jun 14. Oncol Lett. 2019. PMID: 31423282 Free PMC article.
-
Tumor-stroma interactions differentially alter drug sensitivity based on the origin of stromal cells.Mol Syst Biol. 2018 Aug 6;14(8):e8322. doi: 10.15252/msb.20188322. Mol Syst Biol. 2018. PMID: 30082272 Free PMC article.
-
Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts.Biomedicines. 2021 Dec 15;9(12):1921. doi: 10.3390/biomedicines9121921. Biomedicines. 2021. PMID: 34944738 Free PMC article. Review.
-
Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.Neoplasia. 2019 Apr;21(4):413-427. doi: 10.1016/j.neo.2019.03.003. Epub 2019 Mar 27. Neoplasia. 2019. PMID: 30925417 Free PMC article.
-
The obesity-breast cancer link: a multidisciplinary perspective.Cancer Metastasis Rev. 2022 Sep;41(3):607-625. doi: 10.1007/s10555-022-10043-5. Epub 2022 Jun 25. Cancer Metastasis Rev. 2022. PMID: 35752704 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources